MasimoMASI
MASI
About: Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Employees: 3,600
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
66% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 47
29% more call options, than puts
Call options by funds: $7.35M | Put options by funds: $5.71M
17% more repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 115
8% more funds holding
Funds holding: 360 [Q4 2024] → 387 (+27) [Q1 2025]
6% more capital invested
Capital invested by funds: $8.5B [Q4 2024] → $9.02B (+$521M) [Q1 2025]
4.22% more ownership
Funds ownership: 95.97% [Q4 2024] → 100.19% (+4.22%) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 4 [Q4 2024] → 4 (+0) [Q1 2025]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$185
15%
upside
Avg. target
$192
19%
upside
High target
$200
24%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Raymond James Jayson Bedford | 15%upside $185 | Outperform Maintained | 7 May 2025 |
Piper Sandler Jason Bednar | 24%upside $200 | Overweight Reiterated | 7 May 2025 |
Wells Fargo Vik Chopra | 18%upside $190 | Overweight Maintained | 7 May 2025 |
Financial journalist opinion
Based on 5 articles about MASI published over the past 30 days
Neutral
GlobeNewsWire
4 days ago
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.
Neutral
Business Wire
4 days ago
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
NEUCHATEL, Switzerland--(BUSINESS WIRE)-- #Masimo--A new study found that EEG-guided anesthesia using Masimo SedLine® improved anesthesia administration in children undergoing surgery.
Neutral
Business Wire
1 week ago
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders. What can I do? If you are a current Masimo Corporation shareholder, you may have legal claims that may be brought on behalf of the company, against the company's directors and officers. If you wish to discuss this.
Neutral
Business Wire
2 weeks ago
Masimo to Present in the Jefferies Global Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 1:25 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of indus.
Neutral
GlobeNewsWire
3 weeks ago
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.
Positive
Zacks Investment Research
1 month ago
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Neutral
Zacks Investment Research
1 month ago
MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand
Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties.
Neutral
Business Wire
1 month ago
Masimo to Present in the BofA Securities 2025 Health Care Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 4:20 p.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of in.
Neutral
Seeking Alpha
1 month ago
Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript
Masimo Corporation (NASDAQ:MASI ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Katie Szyman - Chief Executive Officer Micah Young - Executive Vice President, Chief Financial Officer Eli Kammerman - Vice President of Business Development, Investor Relations Conference Call Participants Frederick Wise - Stifel Financial Vik Chopra - Wells Fargo Jason Bednar - Piper Sandler Mike Matson - Needham Matt Taylor - Jeffries Michael Polark - Wolfe Operator Good afternoon, ladies and gentlemen. And welcome to Masimo's First Quarter 2025 Earnings Conference Call.
Positive
Zacks Investment Research
1 month ago
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates
Masimo (MASI) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $0.77 per share a year ago.
Charts implemented using Lightweight Charts™